Table 1.
Characteristics | Number | circZFR expression | P | |
---|---|---|---|---|
High | Low | |||
35 | 35 | |||
Age (years) | 0.473 | |||
< 60 | 33 | 15 | 18 | |
≥ 60 | 37 | 20 | 17 | |
Distant metastasis | 0.016* | |||
Present | 32 | 11 | 21 | |
Absent | 38 | 24 | 14 | |
Tumor size (cm) | 0.629 | |||
≤ 2 | 30 | 16 | 14 | |
> 2 | 40 | 19 | 21 | |
TNM stage | 0.002** | |||
I, II | 37 | 25 | 12 | |
III, IV | 33 | 10 | 23 | |
HER-2 status | 0.339 | |||
Positive | 34 | 15 | 19 | |
Negative | 36 | 20 | 16 | |
PR status | 0.229 | |||
Positive | 31 | 13 | 18 | |
Negative | 39 | 22 | 17 | |
ER status | 0.473 | |||
Positive | 37 | 17 | 20 | |
Negative | 33 | 18 | 15 |
HER-2 human epidermal growth factor receptor-2, PR progesterone receptor, ER estrogen receptor
*P < 0.05, **P < 0.01